Immunogenicity of HIV-1 envelope glycoprotein oligomers
- PMID: 20048701
- DOI: 10.1097/COH.0b013e32832edc19
Immunogenicity of HIV-1 envelope glycoprotein oligomers
Abstract
Purpose of review: We summarize and discuss recent developments regarding the immunogenicity of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) oligomers, focusing, for the most part, on trimeric, recombinant protein immunogens.
Recent findings: The three-dimensional cryo-electron tomography images of the HIV-1 Env trimeric spike, coupled with previous data demonstrating the impact on envelope glycoprotein (gp120)-transmembrane glycoprotein (gp41) cleavage of the architecture of the Env trimers, provide exciting information that may lead to new avenues for novel immunogen design. Through new processes to map region-specific anti-Env antibodies present in immune serum, it is now possible to define antibody specificities against conformationally sensitive surfaces of Env. A number of strategies designed to counteract the immunodominance of the HIV-1 Env variable regions were attempted, and a recent study demonstrates that immunization with Env trimers provides sterilizing protection against mucosal challenge with virus. Importantly, protection against the challenge virus was associated with in-vitro HIV-1 neutralization titers.
Summary: Several studies within the past 18 months provide exciting structural information and the development of tools that have the potential to improve Env trimer design and the analysis of trimer immunogenicity studies. The ability to predict protection against a challenge virus through an in-vitro neutralization screen may be very helpful for evaluation of immunogens to move forward into clinical trials.
Similar articles
-
Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.J Virol. 2018 May 29;92(12):e00277-18. doi: 10.1128/JVI.00277-18. Print 2018 Jun 15. J Virol. 2018. PMID: 29618643 Free PMC article.
-
Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes.J Biol Chem. 2017 Sep 22;292(38):15849-15858. doi: 10.1074/jbc.M117.803056. Epub 2017 Jul 25. J Biol Chem. 2017. PMID: 28743743 Free PMC article.
-
Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.J Virol. 2015 Oct;89(20):10383-98. doi: 10.1128/JVI.01653-15. Epub 2015 Aug 5. J Virol. 2015. PMID: 26246566 Free PMC article.
-
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies.Retrovirology. 2018 Sep 12;15(1):63. doi: 10.1186/s12977-018-0445-y. Retrovirology. 2018. PMID: 30208933 Free PMC article. Review.
-
Challenges for structure-based HIV vaccine design.Curr Opin HIV AIDS. 2009 Sep;4(5):431-40. doi: 10.1097/COH.0b013e32832e6184. Curr Opin HIV AIDS. 2009. PMID: 20048708 Review.
Cited by
-
Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer.Biomolecules. 2015 Oct 23;5(4):2919-34. doi: 10.3390/biom5042919. Biomolecules. 2015. PMID: 26512709 Free PMC article.
-
The potential of plant systems to break the HIV-TB link.Plant Biotechnol J. 2019 Oct;17(10):1868-1891. doi: 10.1111/pbi.13110. Epub 2019 Jul 18. Plant Biotechnol J. 2019. PMID: 30908823 Free PMC article. Review.
-
Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization.J Exp Med. 2012 Jun 4;209(6):1091-103. doi: 10.1084/jem.20112655. Epub 2012 May 28. J Exp Med. 2012. PMID: 22641382 Free PMC article.
-
Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection.PLoS One. 2011 Jan 20;6(1):e14548. doi: 10.1371/journal.pone.0014548. PLoS One. 2011. PMID: 21283793 Free PMC article.
-
Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protection.PLoS One. 2011;6(7):e22010. doi: 10.1371/journal.pone.0022010. Epub 2011 Jul 20. PLoS One. 2011. PMID: 21799765 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous